// App-Quantinova.ai

THU0143 : EFFECT OF RITUXIMAB OR TUMOUR NECROSIS FACTOR INHIBITORS ON LUNG INFECTION AND 5-YEAR SURVIVAL IN RHEUMATOID ARTHRITIS-ASSOCIATED BRONCHIECTASIS

Researchers

Presenter

  • M. Y. MD Yusof

Principal Investigators

  • K. Iqbal

  • M. Darby

  • G. Lettieri

  • E. Vital

  • P. Beirne

  • S. Dass

  • P. Emery

  • C. Kelly

Medical Centers

  • University of Leeds, Leeds Institue of Rheumatic and Musculoskeletal Medicine, Leeds, United Kingdom

  • Leeds Teaching Hospitals NHS Trust and NIHR Musculoskeletal Biomedical Research Unit, Leeds, United Kingdom

  • Queen Elizabeth Hospital, Rheumatology, Gateshead, United Kingdom

  • Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom

  • San Carlo Hospital, Radiology, Potenza, United Kingdom

  • Leeds Teaching Hospitals NHS Trust, Childrens Respiratory Medicine, Leeds, United Kingdom

  • University of Newcastle, Institute of Cellular Medicine, Newcastle, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Rheumatoid arthritis

Biomarkers

  • N/A

Drug/Treatment

  • Rituximab

Outcome

  • N/A

Study Design

  • Observational

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • AstraZeneca.

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved